Plant and Agricultural IP Toolkit: Varieties, Seeds, Traits, and Grower Contracts

By Casey Scott McKay · 2026-02-12

Plant and agricultural intellectual property runs on three protection regimes that overlap awkwardly and were built at different times for different purposes. This toolkit collects them. It works the plant patent for asexually reproduced varieties, the Plant Variety Protection Act certificate for seed-propagated ones with its farmer-saved-seed and research exemptions, and the utility patent that carries no exemptions at all and has become the dominant instrument. It then addresses the self-replication problem that exhaustion doctrine handles badly, the technology use agreements that carry most of the commercial control, trait stacking and licensing, germplasm access and deposit obligations, and the enforcement evidence that agricultural cases actually turn on.

IP and Technology > Patent Counseling Transactions | Toolkit | Published 12 February 2026 - Updated 12 March 2026 | Casey Scott McKay - marksy.us

Summary. Plant and agricultural intellectual property runs on three protection regimes that overlap awkwardly and were built at different times for different purposes. This toolkit collects them. It works the plant patent for asexually reproduced varieties, the Plant Variety Protection Act certificate for seed-propagated ones with its farmer-saved-seed and research exemptions, and the utility patent that carries no exemptions at all and has become the dominant instrument. It then addresses the self-replication problem that exhaustion doctrine handles badly, the technology use agreements that carry most of the commercial control, trait stacking and licensing, germplasm access and deposit obligations, and the enforcement evidence that agricultural cases actually turn on.

Keywords: plant IP toolkit · plant patents · Plant Variety Protection Act · utility patents on plants · asexual reproduction · variety certificates · farmer saved seed · research exemption · exhaustion and self replication · Bowman v Monsanto · technology use agreements · grower contracts · trait licensing · stacked traits · germplasm access · deposit requirements · variety naming · seed certification · enforcement evidence · international protection

Start Here

A plant breeder asks what protects a new variety, and the answer depends on how the plant reproduces.

Three regimes, and they were built at different times to solve different problems.

The plant patent at 35 U.S.C. § 161 covers a distinct and new variety of plant that has been asexually reproduced — grafted, budded, rooted from cuttings, or propagated by division. It was the first, enacted because sexually reproduced plants did not breed true and because the written description requirement was thought impossible to satisfy for a living thing. 35 U.S.C. § 162 relaxes the description requirement to what is reasonably possible, and 35 U.S.C. § 163 gives the right to exclude others from asexually reproducing the plant and from using, offering, selling, or importing the plant so reproduced.

The Plant Variety Protection Act certificate covers sexually reproduced and tuber-propagated varieties, administered not by the patent office but by the Department of Agriculture. It requires the variety to be new, distinct, uniform, and stable, and it carries two exemptions that do not exist anywhere else in intellectual property: a research exemption permitting use of the protected variety for breeding, and a farmer's exemption permitting a farmer to save seed for use on their own holding.

The utility patent at 35 U.S.C. § 101 covers plants, seeds, plant parts, genes, traits, transformation methods, and breeding methods. It has no research exemption and no farmer's exemption.

J.E.M. Ag Supply v. Pioneer Hi-Bred International settled the relationship between them, holding that utility patents may issue for plants and that neither the plant patent provisions nor the Plant Variety Protection Act is the exclusive means of protection.

Which is why the utility patent won. A breeder choosing among three regimes chooses the one without exemptions, and the commercial structure of modern agriculture follows from that decision.

And underneath all three sits the problem the doctrine handles worst. These products reproduce themselves. A machine sold does not make more machines; a seed sold makes more seeds, and the buyer who plants it has made something new.

The Three Regimes Compared

Plant patents suit ornamentals, fruit trees, and vines — anything propagated asexually. Term runs twenty years from filing. The claim is to the plant as shown and described, which is narrow, and infringement requires asexual reproduction of that plant rather than independent development of a similar one. 35 U.S.C. § 163 makes independent creation a complete answer, which is unusual in patent law and reflects the biological reality that identical varieties do not arise twice from separate crosses.

Variety certificates suit field crops, vegetables, and grasses. Term is twenty years for most varieties and twenty-five for trees and vines. Protection covers the variety and, importantly, essentially derived varieties — a concept designed to prevent a competitor making a cosmetic change and claiming a new variety. Certificates require a seed deposit maintained in a public repository.

Utility patents suit traits, genes, transformation methods, breeding methods, and — increasingly — the varieties themselves. Claims can reach the seed, the plant, the plant part, the progeny, and the method of use. Term is twenty years from filing. There are no statutory exemptions.

A breeder may hold all three on the same material, and many do: a utility patent on the trait, a variety certificate on the variety, and contractual controls on top.

The strategic questions are cost, disclosure, and exemptions. A variety certificate is cheaper and faster than a utility patent, discloses less, and carries exemptions that permit competitors to breed from the material. A utility patent is expensive, requires enabling disclosure with a deposit, and permits nothing.

The Second-Generation Problem

Bowman v. Monsanto is the case everything turns on.

The facts. A farmer bought commodity soybeans from a grain elevator, planted them, and harvested a crop. The beans contained a patented herbicide-tolerant trait. The farmer argued exhaustion: the seeds had been sold in an authorised sale, so the patent rights in them were spent.

The Supreme Court disagreed unanimously. Exhaustion permits the buyer to use or resell the article sold; it does not permit the buyer to make new articles. Planting a seed to produce a new crop is making, and each generation is a new infringement.

The Court expressly limited the holding to the situation before it, noting that self-replicating products might present different questions where the replication was outside the purchaser's control or was a necessary incident of another use.

Read against Impression Products v. Lexmark International, which held that a patentee's sale exhausts all patent rights regardless of any restriction imposed, the position is coherent: the sale exhausts rights in the seed sold, and it does not license the making of the next generation.

Which means the commercial control does not come from restrictions on the sold seed. It comes from the fact that the buyer cannot lawfully make more.

And it explains the entire structure of the seed industry. Annual purchase is not a contractual imposition holding despite exhaustion; it is the consequence of a patent that reaches the progeny.

Technology Use Agreements and Grower Contracts

The contract layer carries the operational control, and it does work the patent cannot.

What a technology use agreement typically requires. Purchase of seed from an authorised dealer. Planting for a single commercial crop. No saving, no replanting, no supply to others for planting. Compliance with stewardship requirements, including refuge planting for insect-resistance management. Permission for inspection and sampling. Consent to jurisdiction and, frequently, to arbitration. And an acknowledgement of the patents involved.

Why the stewardship terms matter beyond compliance. Insect resistance management obligations exist because resistance destroys the trait's value across the whole market, not just on one farm. They are a shared-resource problem solved by contract.

Enforceability questions arise where the agreement is presented at the point of sale by a dealer rather than negotiated, where it purports to bind successors, and where its restrictions extend beyond the patent's scope. A restriction reaching beyond the claims raises patent misuse considerations, and the intellectual property and antitrust boundary is where those arguments are made.

Distinguish three contract relationships. The technology provider and the seed company, licensing the trait. The seed company and the dealer, governing distribution. The dealer and the grower, imposing the use terms. A defect at any level affects the level below.

And note what the contract cannot do. It does not bind a person who never received it — the grain elevator purchaser in Bowman had no agreement with anyone — which is why the patent claim to progeny is what actually reached that conduct.

Traits, Stacking, and Licensing

A modern commercial variety may carry several traits from several owners, each licensed separately, in a stack that took years to assemble.

Which produces four practical questions.

Freedom to operate across the stack. Every trait, every transformation method, every marker, and every breeding tool. A gap anywhere blocks the whole product.

Royalty stacking. Multiple royalties on one bag of seed, each negotiated separately, with a total that has to remain commercially viable.

Term mismatch. Traits patented at different times expire at different times, and a variety's commercial life may span the expiry of some of its traits and not others. Generic entry on an expired trait while other traits remain protected is now a live commercial reality.

Regulatory approvals travelling with the trait. A trait's approvals in export markets determine where the grain can go, and a stack is limited by its least-approved component. That is a market access constraint no intellectual property analysis addresses.

Cross-licensing is normal in this industry, and the antitrust structuring analysis matters because the participants are few, the arrangements are broad, and the field has attracted regulatory attention.

Germplasm, Deposits, and Access

A utility patent on a plant requires enablement, and the deposit is how it is satisfied where a written description cannot enable a skilled person to reproduce the material.

Deposit obligations run to a recognised depositary, with availability on grant, and with replacement obligations where the deposit becomes non-viable. Failure to maintain a deposit can invalidate the patent.

Variety certificates require a seed deposit maintained in a public repository, which is a different obligation with a different purpose — the certificate's deposit supports the distinctness examination and the eventual public availability of the variety.

Which creates a timing asymmetry worth planning for. Material deposited for a patent becomes available on grant; material deposited for a certificate is held under the Act's terms. A breeder filing both should understand what becomes accessible when.

Germplasm access agreements govern material moving between institutions, and they carry benefit-sharing, publication, and downstream ownership terms. Material received under an agreement carries obligations that travel with any variety bred from it, and a breeding programme that accepted material without reading the terms may discover it does not own what it produced.

International material access frameworks for plant genetic resources for food and agriculture impose their own benefit-sharing obligations on material drawn from multilateral systems, and they are a genuine constraint on commercial breeding programmes.

And the underlying point for a practitioner is provenance. Every accession in a breeding programme should have a documented source and a documented set of terms, recorded when it arrived rather than reconstructed when a product succeeds.

Enforcement, and What the Cases Turn On

Agricultural enforcement is unusual in three ways.

The defendant is frequently sympathetic. A farmer is not a counterfeiter, and enforcement against growers carries reputational consequences that shape strategy.

The evidence is biological. Genetic testing of harvested material establishes the presence of a trait, and the analysis is reliable and expensive.

And the conduct is frequently ambiguous. Cross-pollination happens. Volunteer plants appear. Seed mixes at the elevator. A trait present in a field is not by itself proof of intentional use.

Which makes the evidence file the case. Purchase records, dealer records, planting records, field sampling with documented chain of custody, testing methodology, and the pattern across seasons and fields.

Two doctrinal points that recur.

Innocent presence is a real defence in substance if not in form. Patent infringement is strict liability, and a farmer who did not plant the trait deliberately is nonetheless in possession of infringing material — which is why enforcement policy rather than doctrine governs those cases, and why undertakings and destruction are the usual resolution.

Exhaustion arguments fail on Bowman where the conduct was planting, and may succeed where the conduct was resale of the purchased material as grain rather than as seed.

Remedies follow ordinary patent law: damages under 35 U.S.C. § 284 with a reasonable royalty floor, injunctive relief under 35 U.S.C. § 283 subject to eBay v. MercExchange, and enhanced damages for egregious conduct under the Halo Electronics v. Pulse Electronics standard.

What Operates Independently

Several regimes run alongside intellectual property and constrain it.

Variety naming. A variety denomination is required for a certificate and functions as a generic designation for the variety — which means it cannot serve as a trademark for that variety. Brands and denominations are different things, and confusing them produces a mark that becomes generic on expiry of the protection.

Seed certification schemes govern purity, germination, and labelling, and operate under state and federal seed law entirely separately from any intellectual property right.

Biotechnology regulatory approval determines whether a trait may be planted and where the resulting grain may be sold. Approvals are trait-specific, jurisdiction-specific, and slower than the intellectual property timeline.

Export markets apply their own approval requirements, and asynchronous approval — planted in one country, unapproved in an export destination — is a recurring commercial problem.

Organic certification and coexistence rules govern separation between production systems and create liability questions that are neither patent nor contract.

And the export control regime can reach biological material and associated technology in ways an intellectual property analysis would not predict.

International Protection

The route depends on the material.

Variety protection abroad runs through national plant variety offices under the international union framework, with a priority period and a requirement that the variety be new in the relevant territory — noting that commercialisation elsewhere can destroy novelty on a tighter schedule than patent law's.

Utility patents abroad run through the ordinary international filing route, subject to two significant differences: several major jurisdictions exclude plant and animal varieties and essentially biological processes from patentability, and several provide breeders' exemptions that United States law does not.

Which means the same product may be protected by a utility patent in one market and only by a variety right in another, with different exemptions applying to the same conduct in each. A licensing programme has to be built jurisdiction by jurisdiction rather than on a single global assumption.

Farm-saved seed rules vary considerably, with some jurisdictions permitting it subject to a remuneration obligation and others prohibiting it for particular species.

And the priority and filing deadlines are unforgiving in a field where field trials, variety trials, and regulatory submissions all create disclosure risk.

Choosing the Route

A breeder with a new variety faces a decision that is frequently made by default and should not be.

Start with the propagation biology. Asexual propagation opens the plant patent route; sexual or tuber propagation opens the certificate route; and the utility route is open to both.

Then ask five questions.

Will competitors need to breed from this material? If the answer is yes and the breeder wants that to happen — because the variety's value lies in being a foundation for a segment — a certificate with its research exemption is appropriate. If the answer is no, the utility patent is the instrument, because it forecloses the breeding.

Will growers save seed? For a species where saving is agronomically normal and commercially significant, the 7 U.S.C. § 2543 farmer's exemption under a certificate materially reduces the value of that route, and Asgrow Seed v. Winterboer confirmed the exemption is narrower than growers assumed while leaving it real.

What is the commercial life? A variety with a five-year commercial window does not justify utility patent prosecution costs. A trait platform expected to run for two decades does.

How much disclosure is acceptable? A utility patent requires enabling disclosure with a deposit that becomes available on grant. A certificate discloses the variety description and holds the deposit under the Act's terms. A breeder with a valuable parental line may not want either, and may prefer trade secret protection on the inbreds while protecting only the hybrid.

What is the international plan? Several major jurisdictions exclude plant varieties from patentability and provide breeders' exemptions, which means the utility route may be available in the home market and unavailable in the largest export market.

The hybrid strategy is common and sensible. Trade secret on the parental inbred lines, a certificate on the hybrid, a utility patent on any novel trait, and contractual controls on the commercial seed. Each layer covers a different failure mode.

Record the decision and the reasoning. Route selection is revisited when a product succeeds unexpectedly, and reconstructing why a certificate was chosen over a patent eight years later is not possible from the file alone.

Diligence Questions

When acquiring, licensing in, or financing an agricultural business, ten questions surface most of the problems.

What is protected, by which instrument, and when does each expire? A portfolio mixing plant patents, certificates, utility patents, and trade secrets has four expiry schedules and four different scopes.

Is every accession in the breeding programme documented? Source, date, and the terms under which it arrived. Germplasm received under a material transfer agreement carries obligations that travel into anything bred from it, and an undocumented programme cannot demonstrate that it does not.

Are the deposits current and viable? A utility patent whose deposit has become non-viable and was not replaced is vulnerable, and the replacement obligation is easy to miss across an ownership change.

What does the trait stack contain, and who owns each element? Including transformation methods, markers, and breeding tools, not only the traits themselves.

What royalties attach to each element, and what is the total per unit? Stacking is the recurring commercial problem and it is not visible from any single agreement.

Which regulatory approvals exist, in which jurisdictions, and who holds them? Approvals are trait-specific and travel with the trait rather than with the variety, and a stack is limited by its least-approved component.

What is the technology use agreement architecture? Trait provider to seed company, seed company to dealer, dealer to grower. A defect at any level undermines the levels below.

Has enforcement been consistent? Sporadic enforcement against growers creates both reputational and evidentiary problems, and a portfolio with a history of ignored infringement is worth less than one with a documented programme.

Are the variety denominations distinct from the trademarks? A denomination cannot function as a mark for the variety it names, and a business that branded on the denomination has nothing at expiry.

And what happens on expiry? Generic entry on an expired trait while other traits in the same variety remain protected is the current commercial reality, and a business plan that assumed the whole product falls off a cliff at one date is wrong in both directions.

Eligibility, and the Line That Moved

Living material has been patentable subject matter for a long time, and the boundary has shifted twice in ways that matter here.

Diamond v. Chakrabarty held that a live human-made microorganism was patentable subject matter under 35 U.S.C. § 101, on the reasoning that the relevant distinction is between products of nature and human-made inventions rather than between living and inanimate matter.

J.E.M. Ag Supply v. Pioneer Hi-Bred International applied that to plants, confirming that utility patents may issue for plants notwithstanding the existence of the two specialised regimes.

Association for Molecular Pathology v. Myriad Genetics then narrowed the position for genetic material, holding that a naturally occurring DNA segment is a product of nature and not patent eligible merely because it has been isolated, while complementary DNA is eligible because it is not naturally occurring.

Which matters practically in three ways.

Native trait claims are harder. A gene sequence found in a wild relative and introgressed into a commercial variety is not eligible merely for having been identified and moved, and claims have to be drafted to the engineered construct, the method, or the transformed plant rather than to the sequence as such.

Method claims carry more weight, and they need to survive the eligibility framework applied to processes as well.

Marker-assisted selection claims occupy contested ground, because a method of selecting plants by reference to a naturally occurring marker looks like the application of a natural correlation.

None of this affects the plant patent or the certificate, which are creatures of their own statutes with their own requirements — a point worth remembering when eligibility becomes the obstacle on the utility route.

And 35 U.S.C. § 112 remains the practical constraint on breadth. A claim to a trait defined by function rather than by structure faces written description and enablement problems that the deposit does not cure, and the scope actually obtainable is frequently narrower than the commercial ambition.

Common Errors

Treating the three regimes as alternatives rather than layers. They cover different things with different scope and different exemptions, and the strong position uses several at once.

Choosing the certificate route without pricing the exemptions. The 7 U.S.C. § 2544 research exemption permits competitors to breed from the protected variety, and the 7 U.S.C. § 2543 farmer's exemption permits saving for use on the holding. Both are real, and a business model assuming exclusivity under a certificate is built on a mistake.

Assuming exhaustion protects the grower. Bowman v. Monsanto is unanimous and clear: planting is making, and the sale of a seed does not license the next generation.

Relying on the contract where the patent does the work. The technology use agreement adds stewardship, inspection, and dispute terms; it is the patent claim to progeny that reaches the person who never signed anything.

Branding on the variety denomination. A denomination functions as a generic designation for the variety and cannot be a trademark for it. Build a separate brand.

Letting a deposit lapse. A non-viable deposit that was not replaced can invalidate the patent it enabled, and the obligation survives an ownership change that nobody flagged.

Ignoring germplasm provenance until a product succeeds. Material received under a transfer agreement carries obligations into anything bred from it, and an undocumented programme cannot show otherwise.

Assuming approvals travel with the variety. They travel with the trait, they are jurisdiction-specific, and a stack is limited by its least-approved component.

Filing late relative to field trials. Variety trials, demonstration plots, and regulatory submissions all create disclosure risk on schedules tighter than patent law's grace period and much tighter than the novelty rules for variety protection abroad.

And enforcing inconsistently. Sporadic action against growers produces reputational damage and an evidentiary record that undermines the next case.

Cadence

Annually, five items.

The portfolio schedule. Every plant patent, certificate, and utility patent by expiry date, with the traits and varieties each covers, so the expiry cliff is visible several seasons ahead rather than in the year it arrives.

Deposit viability. Confirm with the depositary that every deposit supporting a live patent or certificate remains viable, and replace where it does not.

Germplasm provenance. Confirm that every accession added in the year was documented at intake with its source and terms, and sample the historic file to test whether the practice is real.

Regulatory approval map. Trait by trait, jurisdiction by jurisdiction, against the export destinations the grain actually reaches. Asynchronous approval is the recurring commercial exposure and it changes annually.

Enforcement summary. Matters opened, testing performed, resolutions reached, and the pattern of conduct observed. This is the record that supports the next case and the record that a regulator or acquirer will ask for.

Each season, three more.

Confirm the technology use agreement architecture is intact from trait provider through seed company and dealer to grower, including that the current-season version is the one actually being presented at point of sale.

Check the stewardship compliance data, particularly refuge planting where insect resistance management obligations apply, because resistance destroys the trait's value across the whole market rather than on one farm.

And review the denomination and brand separation for anything newly named, before the denomination is used in marketing as though it were the brand.

A Closing Note

This field is unusual in that the doctrine and the biology disagree.

Intellectual property assumes an article that stays sold. A seed does not. It makes more of itself, and the person who plants it has manufactured rather than used — which Bowman recognised and which no exhaustion doctrine written for machines anticipated.

Two specialised regimes were built for the problem and both carry exemptions. The utility patent, built for nothing in particular, carries none — and that is why it became the dominant instrument in a sector it was never designed for.

The practical consequence for a practitioner is that the strong position is layered, the exemptions are the deciding factor in route selection, and the contract layer supports the patent rather than substituting for it.

And the evidence file — provenance, deposits, approvals, agreements, and testing records — is what makes any of it enforceable.

Sectors Within the Sector

Row crops — maize, soybean, cotton, canola. The utility patent and trait stack model in its purest form, with technology use agreements, stewardship obligations, and annual purchase as the norm. Enforcement is systematic and testing-driven, and the expiry of foundational traits has created a genuine generic segment.

Small grains and pulses — wheat, barley, rice, dry beans. Historically certificate-protected with active farmer saving, and the economics of the 7 U.S.C. § 2543 exemption shape the whole business model. Public breeding programmes remain significant, which changes the licensing landscape.

Vegetables. Hybrid seed with valuable parental inbreds, where trade secret on the inbreds does more work than any registered right, and where the certificate protects the commercial hybrid.

Fruit and nut trees, and vines. The plant patent's natural home, propagated asexually, with long establishment periods, and with enforcement that runs against nurseries rather than growers. The twenty-five year certificate term for trees and vines matters here.

Ornamentals. High variety turnover, plant patents filed in volume, and enforcement against propagators. Denomination and brand separation is a recurring failure in this segment because varieties are marketed by name.

Turf and forage grasses. Certificate-protected, with seed certification schemes doing much of the commercial work and with a market where purity and identity matter as much as protection.

Potatoes and other tuber crops. Covered by the certificate route expressly, with seed potato certification operating as a parallel and equally consequential regime.

Biologicals and inputs — microbial products, biostimulants, biopesticides. Ordinary utility patent and trade secret practice, with Chakrabarty as the foundation and a regulatory approval path of its own.

Precision agriculture and data. Not a plant question at all: software, sensors, and agronomic data, governed by patent, copyright, and data licensing, with grower data ownership as a live commercial issue that the seed contracts increasingly address.

Building the Enforcement Programme

Enforcement in this sector is a programme rather than a series of cases, and the design decisions matter more than the doctrine.

Set the threshold. Which conduct triggers action — commercial-scale saving, brown-bagging for sale to others, unlicensed multiplication by a competitor, or trait presence at levels consistent with adventitious spread. Publish the threshold internally so field staff apply it consistently.

Design the sampling protocol before the first case. Who takes the sample, from where in the field, with what documentation, into what chain of custody, and to which laboratory. A protocol designed during a dispute is a protocol the defendant will attack.

Validate the testing methodology. Trait detection is reliable and its limits matter — detection thresholds, the treatment of mixed lots, and the difference between presence and commercial-scale use.

Separate the three fact patterns. Deliberate saving and replanting is the core case. Brown-bagging — cleaning and selling saved seed to others — is the aggravated case and the one that justifies the strongest response. Adventitious presence from cross-pollination or volunteers is not a case at all, and pursuing it damages the programme.

Use graduated responses. A letter, a compliance meeting, an undertaking with destruction of the material, a settlement with a licence for past use, and litigation as the last step. Most matters resolve at the first three, and the ones that do not are the ones worth the file.

Document the pattern across seasons. A single season's trait presence proves little; a pattern across fields and years proves intent.

Watch the remedies. 35 U.S.C. § 284 supplies damages with a reasonable royalty floor, and the technology fee for the relevant season is the natural royalty measure. 35 U.S.C. § 283 injunctions are subject to eBay, and enhanced damages require the egregiousness that Halo describes — which brown-bagging can supply and inadvertent presence cannot. 35 U.S.C. § 285 fee awards cut both ways in a sector where a defendant may be an individual farmer.

And run the reputational analysis alongside the legal one. Monsanto v. McFarling confirmed the technology agreements are enforceable, and the cases that followed shaped public perception of the industry for two decades. Enforcement policy in this sector is a communications decision as much as a legal one.

Public Breeding, Universities, and Spin-Outs

A large share of variety development happens in public institutions, and the intellectual property arrangements differ in ways worth knowing.

Public breeding programmes release varieties under a range of arrangements: unprotected public release, certificate protection with broad licensing, exclusive licences to a commercial partner, and increasingly utility patents on traits developed with commercial funding.

Federal funding brings its own framework. Where research was federally funded, the technology transfer regime governs election of title, government licence rights, march-in provisions, and reporting obligations. A commercial partner licensing a publicly developed variety is taking rights subject to all of it.

Material transfer agreements are the operative documents in university breeding, and they carry provenance, publication, and downstream ownership terms that follow into anything bred from the material. A programme that accepted germplasm on standard academic terms and then attempts an exclusive commercial licence discovers the constraint late.

Publication pressure conflicts with filing timing. Academic breeders publish; variety descriptions, field trial results, and conference presentations are disclosures. The university and research institution agreements discipline exists partly to manage that conflict, and it is more acute here than in most fields because the disclosure is a physical plant in a public trial.

Spin-out formation carries the ordinary questions plus one specific to this sector: the germplasm the spin-out needs may be encumbered by transfer terms the parent institution accepted decades ago and cannot now vary.

And the licensing negotiation has an unusual feature. Public institutions frequently retain a right to continue breeding with the material and to release further varieties from it, which a commercial licensee expecting exclusivity has to price and frequently does not.

One further point about timing. Variety development takes years and intellectual property deadlines do not. A programme that starts thinking about protection when a variety is ready for release has usually already disclosed it in a trial, published a description, or distributed material for evaluation — each of which starts a clock somewhere. The discipline that works is a filing decision made at the point a candidate enters replicated trials, revisited annually, rather than a decision made at commercial release.

And the same discipline applies to the denomination. Choose it at trial entry, confirm it is available and acceptable to the registration authority, and choose a separate commercial brand at the same moment — before marketing has spent two seasons building recognition in a word that will become generic on expiry.

Two decisions, made at the same meeting, years before either matters — which is characteristic of everything in this toolkit and is the single most useful thing to take from it.

Get the route decision, the filing trigger, and the naming decision onto the trial-entry agenda, and the rest of this toolkit becomes maintenance.

Everything else here is a variation on those three, applied to a different crop or a different regime.

A Suggested Reading Path

Start with the doctrine in Owning a Living Thing, which works the three regimes and the second-generation problem.

Then the operations in Protecting and Licensing Plant and Agricultural Innovation.

Then the audit in the plant and agricultural checklist.

For the exhaustion background, read The Sale That Ends Your Rights and, for the self-replication parallel in durable goods, The Part That Broke.

For the patent fundamentals underneath the utility route, the Patent Fundamentals Toolkit.

For licensing structure, Where Intellectual Property Stops and Antitrust Starts and the IP and Antitrust Toolkit.

For international filing, the International Patent Toolkit and the priority checklist.

And for the freedom-to-operate work that a trait stack requires, the Freedom to Operate and Patent Clearance Toolkit.

Primary Authorities

| Authority | Proposition | |---|---| | 35 U.S.C. § 101 | Patentable subject matter | | 35 U.S.C. § 102 | Novelty; prior art | | 35 U.S.C. § 103 | Obviousness | | 35 U.S.C. § 112 | Written description; enablement | | 35 U.S.C. § 161 | Plant patents | | 35 U.S.C. § 162 | Plant patent description | | 35 U.S.C. § 163 | Plant patent rights | | 35 U.S.C. § 271 | Infringement | | 35 U.S.C. § 283 | Injunctions | | 35 U.S.C. § 284 | Damages | | 35 U.S.C. § 285 | Exceptional case fees | | 7 U.S.C. § 2321 | Plant Variety Protection Act | | 7 U.S.C. § 2402 | Requirements for protection | | 7 U.S.C. § 2483 | Certificate contents and term | | 7 U.S.C. § 2543 | Farmer's exemption | | 7 U.S.C. § 2544 | Research exemption | | J.E.M. Ag Supply v. Pioneer Hi-Bred International | Utility patents for plants | | Bowman v. Monsanto | Planting is making, not using | | Impression Products v. Lexmark International | Exhaustion on sale | | Quanta Computer v. LG Electronics | Exhaustion by authorised sale | | Asgrow Seed v. Winterboer | Scope of the farmer's exemption | | Diamond v. Chakrabarty | Living matter as subject matter | | Association for Molecular Pathology v. Myriad Genetics | Isolated DNA; cDNA | | eBay v. MercExchange | Injunctive relief standard | | Halo Electronics v. Pulse Electronics | Enhanced damages | | Monsanto v. McFarling | Technology agreements enforceable | | International plant variety protection framework | Breeders' rights abroad | | Plant genetic resources access frameworks | Germplasm access and benefit sharing | | Seed certification and labelling law | Seed regulation | | Biotechnology regulatory approval | Trait approvals |

Forms and Templates

The License Agreement Template supplies the structure for a trait or variety licence, with the field-of-use, territory, royalty, and audit provisions that a stacked-trait arrangement requires. A technology use agreement is a narrower instrument built on the same skeleton, adding stewardship obligations, inspection and sampling rights, and the single-season planting restriction that the patent claim to progeny makes meaningful. Germplasm transfer agreements should be treated as a separate template with their own provenance, benefit-sharing, publication, and downstream ownership terms.

Related Toolkits and Checklists

The Patent Fundamentals Toolkit carries the eligibility, novelty, and disclosure doctrine underpinning the utility route. The Freedom to Operate and Patent Clearance Toolkit is the discipline a trait stack requires. The International Patent Toolkit covers the filing routes abroad, and the Exhaustion and Gray Market Toolkit covers the first-sale doctrine this field stretches hardest. For licensing structure and its limits, use the IP and Antitrust Toolkit.